As in infant leukemia cells, BLK was the second most upregulated gene in pediatric KMT2A/MLL-R+ ALL cells showing a 4.38-fold higher expression level than in normal hematopoietic cells (P-value < 1 × 10-8). This evidence concerns the gene KMT2A and leukemia.